Business · 18/04/2019Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Proposed Rule on Over-the-Counter Sunscreen Products
Summary
The Food and Drug Administration (FDA) is extending the comment period for its proposed rule on regulating over-the-counter (OTC) sunscreen monograph products, following a request from interested persons for additional time to submit comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →